Evaluating the efficacy of Guduchi Rasayana followed by Shamanoushadhi as add-on therapy to Thyroxine sodium in the management of Primary hypothyroidism (Medoroga) –A randomized controlled clinical trial. - NI

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Age 21 to 50 Years
•TSH Levels more than or equal to 5.6mIU/L to less than or equal to 10mIU/L patients will be included only after 8 weeks of stable thyroxine dosage who followed the regimen in the correct way.

•EXCLUSION CRITERIA:
•Patient having TSH level greater than >10.0 mIU/ L.
•Recent/post thyroid surgery or radio-iodine (within 12 months).
•Uncontrolled blood sugar (FBS-125 mg/dl PPBS- 180 mg/dl) hypertension SBP >140, DBP >90 mm of Hg
•Recent acute coronary syndrome, including myocardial infarction or unstable angina.
•Suffering from diseases like HIV, tuberculosis, encephalopathy, goiter, other endocrine disorders (except Type 2 DM) and other autoimmune disorders.
•Pregnancy, lactation.

发起方